Hee Sook Park

722 total citations
49 papers, 531 citations indexed

About

Hee Sook Park is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Hematology. According to data from OpenAlex, Hee Sook Park has authored 49 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 13 papers in Pulmonary and Respiratory Medicine and 11 papers in Hematology. Recurrent topics in Hee Sook Park's work include Colorectal Cancer Treatments and Studies (6 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Hee Sook Park is often cited by papers focused on Colorectal Cancer Treatments and Studies (6 papers), Acute Myeloid Leukemia Research (5 papers) and Retinoids in leukemia and cellular processes (4 papers). Hee Sook Park collaborates with scholars based in South Korea and United States. Hee Sook Park's co-authors include Jong-Ho Won, Dae Sik Hong, Sang‐Cheol Lee, Chan Kyu Kim, Sang Byung Bae, Hyun Jung Kim, Kyoung Ha Kim, Kyu Taek Lee, Sung Kyu Park and Han Jo Kim and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Breast Cancer Research and Treatment.

In The Last Decade

Hee Sook Park

44 papers receiving 516 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hee Sook Park South Korea 14 197 132 112 110 68 49 531
Dae Sik Hong South Korea 14 252 1.3× 154 1.2× 133 1.2× 111 1.0× 44 0.6× 64 640
Kyu Taek Lee South Korea 13 140 0.7× 118 0.9× 92 0.8× 52 0.5× 46 0.7× 32 376
AK Kakkar United Kingdom 7 161 0.8× 88 0.7× 164 1.5× 125 1.1× 92 1.4× 11 755
Serdar Soyuer Türkiye 11 124 0.6× 184 1.4× 137 1.2× 109 1.0× 40 0.6× 19 756
G. Salerno Italy 13 197 1.0× 53 0.4× 133 1.2× 78 0.7× 41 0.6× 20 552
Jeremy Lawrance United Kingdom 14 160 0.8× 123 0.9× 157 1.4× 150 1.4× 52 0.8× 35 742
R. Hartenstein Germany 14 124 0.6× 142 1.1× 261 2.3× 116 1.1× 35 0.5× 59 582
Umut Kefeli Türkiye 12 173 0.9× 260 2.0× 184 1.6× 95 0.9× 67 1.0× 40 583
Jennifer Herring United States 11 347 1.8× 175 1.3× 137 1.2× 180 1.6× 41 0.6× 21 788
Syamal D. Bhattacharya United States 18 219 1.1× 480 3.6× 337 3.0× 271 2.5× 133 2.0× 47 1.2k

Countries citing papers authored by Hee Sook Park

Since Specialization
Citations

This map shows the geographic impact of Hee Sook Park's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hee Sook Park with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hee Sook Park more than expected).

Fields of papers citing papers by Hee Sook Park

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hee Sook Park. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hee Sook Park. The network helps show where Hee Sook Park may publish in the future.

Co-authorship network of co-authors of Hee Sook Park

This figure shows the co-authorship network connecting the top 25 collaborators of Hee Sook Park. A scholar is included among the top collaborators of Hee Sook Park based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hee Sook Park. Hee Sook Park is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Sung‐Bae, Changhoon Yoo, Jungsil Ro, et al.. (2014). Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: Randomized phase II multicenter trial. Investigational New Drugs. 32(4). 753–761. 4 indexed citations
2.
3.
4.
5.
Kim, Hyun Jung, Jina Yun, Han Jo Kim, et al.. (2012). Phase II study of palliative S-1 in combination with cisplatin as second-line chemotherapy for gemcitabine-refractory pancreatic cancer patients. Oncology Letters. 3(6). 1314–1318. 9 indexed citations
6.
Kim, Han Jo, Young‐Woo Jeon, Jina Yun, et al.. (2011). Efficacy and Safety of Oxaliplatin, 5-Fluorouracil, and Folinic Acid Combination Chemotherapy as First-Line Treatment in Metastatic or Recurrent Gastric Cancer. Cancer Research and Treatment. 43(3). 154–159. 10 indexed citations
7.
Kim, Han Jo, Kyoung Ha Kim, Jina Yun, et al.. (2011). Phase II Clinical Trial of Genexol(R) (Paclitaxel) and Carboplatin for Patients with Advanced Non-small Cell Lung Cancer. Cancer Research and Treatment. 43(1). 19–23. 12 indexed citations
8.
Kim, Hyun Jung, Sang‐Cheol Lee, Sang Byung Bae, et al.. (2009). A phase II study of gemcitabine in combination with oxaliplatin as first-line chemotherapy in patients with inoperable biliary tract cancer. Cancer Chemotherapy and Pharmacology. 64(2). 371–377. 22 indexed citations
9.
Yoon, Jin A, Chan Kyu Kim, Se Hyung Kim, et al.. (2009). Initial Therapy with High-Dose Dexamethasone for Patients with Idiopathic Thrombocytopenic Purpura. The Korean Journal of Hematology. 44(1). 22–22. 1 indexed citations
10.
Choi, Dongho, Jung Hoon Kim, Mi‐sun Lim, et al.. (2008). Hepatocyte-Like Cells from Human Mesenchymal Stem Cells Engrafted in Regenerating Rat Liver Tracked with In Vivo Magnetic Resonance Imaging. Tissue Engineering Part C Methods. 14(1). 15–23. 21 indexed citations
11.
Choi, Doo Ho, Min Hyuk Lee, Hee Sook Park, et al.. (2008). The CHEK2 1100delC mutation is not present in Korean patients with breast cancer cases tested for BRCA1 and BRCA2 mutation. Breast Cancer Research and Treatment. 112(3). 569–573. 27 indexed citations
12.
Kang, Myung Soo, Kyoung Ha Kim, Sang Chul Lee, et al.. (2007). Influential Factors for Engraftment in Autologous Peripheral Hematopoietic Stem Cell Transplantation (APBSCT). The Korean Journal of Hematology. 42(4). 301–301.
13.
Kim, Hyun Jung, Sang Byung Bae, Chan Kyu Kim, et al.. (2006). Autoimmune Hemolytic Anemia in Myelodysplastic Syndrome. The Korean Journal of Hematology. 41(4). 317–317.
14.
Choi, Soo Jeong, et al.. (2002). A Case of Refractory Henoch-Schonlein Purpura Treated with Thalidomide. The Korean Journal of Internal Medicine. 17(4). 270–273. 8 indexed citations
15.
Won, Jong-Ho, et al.. (2000). Thrombopoietin Is Synergistic with Other Cytokines for Expansion of Cord Blood Progenitor Cells. Journal of Hematotherapy & Stem Cell Research. 9(4). 465–473. 13 indexed citations
16.
Hong, Kun, Hee Sook Park, & Young‐Uk Kwon. (1999). Trinuclear complexes M[Co(en) 2 (SO 3 ) 2 ] 2 (H 2 O) 2 ·4H 2 O (M=Mn, Fe, Co, Ni, Cu, Zn): their utilization for stoichiometric spinel oxides and the crystal structure of Ni[Co(en) 2 (SO 3 ) 2 ] 2 (H 2 O) 2 ·4H 2 O. Bulletin of the Korean Chemical Society. 20(2). 163–167. 2 indexed citations
17.
Kim, Chan Kyu, Sung Kyu Park, Dong Won Kim, et al.. (1998). A Case of CMV Disease of the Jejunum in a Patient with Non - Hodgkin`s Lymphoma. The Korean Journal of Internal Medicine. 13(2). 143–146. 7 indexed citations
18.
Cho, Sung Tae, et al.. (1997). A Case of Coagulation Factor 5 Deficiency Complicated with Intracranial Hemorrhage. The Korean Journal of Internal Medicine. 12(1). 80–83. 3 indexed citations
19.
Park, Sung Kyu, et al.. (1995). A Case of Granulocytic Sarcoma of the Brain in a Patient with Myelodysplastic Syndrome. The Korean Journal of Internal Medicine. 10(2). 160–163. 2 indexed citations
20.
Won, Jong-Ho, et al.. (1993). Acute Appendicitis in Patients with Acute Leukemia. The Korean Journal of Internal Medicine. 8(1). 40–46. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dae Sik Hong Breakdown of academic impact, for papers by Kyu Taek Lee Breakdown of academic impact, for papers by AK Kakkar Breakdown of academic impact, for papers by Serdar Soyuer Breakdown of academic impact, for papers by G. Salerno Breakdown of academic impact, for papers by Jeremy Lawrance Breakdown of academic impact, for papers by R. Hartenstein Breakdown of academic impact, for papers by Umut Kefeli Breakdown of academic impact, for papers by Jennifer Herring Breakdown of academic impact, for papers by Syamal D. Bhattacharya
Rankless by CCL
2026